Ruedi Aebersold

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients.

Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

Hadassah University Hospital engages in the operation of hospitals and medical centers in Israel and abroad. Its services include hospitalization services, medical services, medical tourism, and research and development. The company was founded in 1934 and is headquartered in Jerusalem, Israel.

Genomatix GmbH develops genomic data analysis and interpretation software solutions. Its focus areas encompass sequencing data analysis, expression profiles, proprietary genome annotation, comparative genomics, and network data and pathways. The firm develops software technologies for variant detection, transcript interpretation, and gene mapping and regulation applications. It also offers data integration, consulting, and assembly and annotation services. The company was founded in 1997 and is headquartered in Munich, Germany.

Curetis GmbH operates as a molecular diagnostics company which focuses on the development and commercialization of products for diagnosing severe infectious diseases. The firm offers diagnostic solutions for hospitals and large-scale laboratories. Its products include Unyvero L4 Lysator, Unyvero C8 Cockpit, Unyvero A50 Analyzer, and Unyvero Application Cartridges. The company was founded by Andreas Boos, Johannes Bacher, Gerd Lüdke, and Anne Thews in August 2007 and is headquartered in Holzgerlingen, Germany.

Part of Wilh. Werhahn KG, HUMAN Gesellschaft für Biochemica und Diagnostica mbH is a healthcare company based in Wiesbaden, Germany. HUMAN has been serving the healthcare sector for 50 years with high-quality products, renowned services, and individualized support. With R&D and production anchored in and with partners in more than 160 countries, HUMAN is regarded as a player in the IVD industry. The German company's worldwide network of subsidiaries and distributors guarantees being close to the users, providing service and support. HUMAN offers a constant supply of products and support, and its customers' satisfaction is its success. The company was founded in 1972. Ralph Neuberger has been the CEO of the company since 2002.

BiognoSYS AG operates as a biotechnology company. Its products include iRT Kit, HRM Kit, Sample Prep Kit, PlasmaDive, Spectronaut and SpectroDive. The company was founded by Philipp M. Antoni, Johan Malmstroem and Oliver Rinner on September 3, 2008 and is headquartered in Schlieren, Switzerland.

Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel.

Part of Ostdeutscher Sparkassenverband, LBS Ostdeutsche Landesbausparkasse AG is a German company that offers savings options for employees through Vermögenswirksamen Leistungen (VL). The company is based in Potsdam, Germany. LBS provides the highest level of security for its customers' savings through its deposit insurance system, which has not resulted in any losses for customers since its establishment in the 1970s. The CEO of the company is Werner Schäfer.

Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland.

INDICAL BIOSCIENCE GmbH provides solutions for molecular diagnostics for vet-specific applications. It offers diagnostics for better animal and human health. The company was founded in 1996 and is headquartered in Leipzig, Germany.

Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA.

Part of AdhexPharma SAS, tesa Labtec GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The company is based in Langenfeld, Germany. The company was founded in 1990 by Günter Cordes. The CEO is Detlev Radloff. tesa Labtec was acquired by AdhexPharma SAS from maxingvest AG on September 30, 2022.

Fondation De l'Hôpital Barrie Memorial is a private company based in Ormstown, Canada. The Canadian company engages in raising funds to improve health care and services.

Virometix AG is a Swiss biotechnology company that focuses on developing vaccines and immunotherapeutic drugs for the prevention and treatment of infections and cancer. Virometix is based in Schlieren, CH. The private company's mission is to address the growing medical need for vaccines to combat infectious and chronic human diseases. The company was founded by John Anthony Robinson, and the CEO is Anna Sumeray.

TOLREMO therapeutics AG engages in discovering and developing therapies for treating cancer patients. The firm serves on academic research laboratories, flourishing life sciences spin-offs and cutting-edge technology platforms. The company was founded by Stefanie Flückiger-Mangual, Wilhelm Krek, Karl-Heinz Altmann, Isaac Kobrin, and Emmanuel Savioz in March 2017 and is headquartered in Zurich, Switzerland.

NeraCare GmbH operates clinics. The company is based in Cologne, Germany. The German company was founded by Daniel von Janowski and Friedrich Ackermann. Daniel von Janowski has been the CEO since incorporation.

Indical Topco AB is a Swedish company that owns and manages shares, as well as real and movable properties. The private company is based in Stockholm, Sweden.

Avelo AG is a Swiss company that aims to save lives by providing fast and actionable infectious disease diagnosis closer to the patient. Avelo is based in Schlieren, CH. The company's solution is a breath collection device that works with existing molecular tests to detect multiple respiratory tract infections causing pneumonia. The company was founded in 2020 by Melanie Aregger and Tobias Broger, with Melanie Aregger serving as the CEO since 2020.

Part of Abbott Laboratories, Abbott Diagnostics GmbH is a German company that manufactures and distributes diagnostic healthcare equipment and products. The company is based in Wiesbaden, Germany. The CEOs are Edita Apuokiené and Robert Emmett Funck. The company was founded in 1995.